Emilia Lunguţ *, D. Vasile **
* Dr. Emilia Lunguţ, medic primar neurologie SCMC
** Dr. D. Vasile, medic primar psihiatrie SCMC
Abstract
Relapse prevention in alcohol dependence treatment remain a major chalenge for neuropsychopharmacology. This purpose is realised with anticraving drugs, which mechanism was recently discovered: acamprosate (NMDA receptor antagonist), naltrexone (opioid receptor antagonist), fluoxetine, fluvoxamine (selective serotonine recapture inhibitors).